blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4021905

EP4021905 - INHIBITORS OF ADRENORECEPTOR ADRAC2 [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  17.02.2023
Database last updated on 26.06.2024
FormerRequest for examination was made
Status updated on  03.06.2022
FormerThe international publication has been made
Status updated on  14.05.2021
Formerunknown
Status updated on  10.11.2020
Most recent event   Tooltip28.10.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Bayer Aktiengesellschaft
Kaiser-Wilhelm-Allee 1
51373 Leverkusen / DE
[2022/27]
Inventor(s)01 / DELBECK, Martina
Müllerweg 10
42579 Heiligenhaus / DE
02 / HAHN, Michael
Rietherbach 42D
40764 Langenfeld / DE
03 / MÜLLER, Thomas
Parkstraße 24
40764 Langenfeld / DE
04 / DIETZ, Lisa
An der Grenze 17
42111 Wuppertal / DE
05 / PLATZK, Magdalena
200 Hyslop Rd
Brookline, MA 02445 / US
06 / MEIBOM, Daniel
In den Birken 62b
42113 Wuppertal / DE
07 / BUCHGRABER, Philipp
Kastanienallee 25
10435 Berlin / DE
08 / LINDNER, Niels
Düsseldorfer Strasse 47
42115 Wuppertal / DE
09 / BECKER-PELSTER, Eva Maria
Düsseler Höhe 22
42327 Wuppertal / DE
10 / SCHMECK, Carsten
Carl-Friedrich-Goerdeler-Straße 24
45472 Mülheim / DE
 [2022/27]
Representative(s)BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 50
40789 Monheim am Rhein / DE
[2022/27]
Application number, filing date20800159.405.11.2020
[2022/27]
WO2020EP81097
Priority number, dateEP2019020753606.11.2019         Original published format: EP 19207536
[2022/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021089683
Date:14.05.2021
Language:EN
[2021/19]
Type: A1 Application with search report 
No.:EP4021905
Date:06.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 14.05.2021 takes the place of the publication of the European patent application.
[2022/27]
Search report(s)International search report - published on:EP14.05.2021
ClassificationIPC:C07D413/14, C07D417/14, A61K31/454, A61P9/00, A61P11/00, A61P25/00
[2022/27]
CPC:
C07D417/14 (EP,IL,KR); C07D417/12 (US); A61K31/4545 (EP,KR);
A61K31/4725 (EP); A61K31/55 (EP); A61K45/06 (EP);
A61P11/00 (EP,IL,KR); A61P25/00 (EP,IL,KR); A61P9/00 (EP,IL,KR);
C07D277/28 (US); C07D413/12 (US); C07D413/14 (EP,IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/27]
Extension statesBA30.03.2022
ME30.03.2022
Validation statesMA30.03.2022
TN30.03.2022
TitleGerman:INHIBITOREN VON ADRENOREZEPTOR ADRAC2[2022/27]
English:INHIBITORS OF ADRENORECEPTOR ADRAC2[2022/27]
French:INHIBITEURS DE L'ADRÉNORÉCEPTEUR ADRAC2[2022/27]
Entry into regional phase30.03.2022National basic fee paid 
30.03.2022Designation fee(s) paid 
30.03.2022Examination fee paid 
Examination procedure30.03.2022Examination requested  [2022/27]
30.03.2022Date on which the examining division has become responsible
28.10.2022Amendment by applicant (claims and/or description)
21.02.2023Despatch of a communication from the examining division (Time limit: M06)
21.08.2023Reply to a communication from the examining division
Fees paidRenewal fee
26.10.2022Renewal fee patent year 03
27.10.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2008060568  (NEUROGEN CORP [US], et al) [A] 1-16* claims 1, 85, 86; compounds 76-80 *;
 [A]WO2015091415  (BAYER PHARMA AG [DE]) [A] 1-16 * page 161; examples 43, 45, 50, 53, 54, 56, 70-98, 104, 105; claim 1 *;
 [AD]WO2015091420  (BAYER PHARMA AG [DE]) [AD] 1-16 * page 74; claim 1 *
by applicantUS3966781
 WO0006568
 WO0006569
 WO0119355
 WO0119776
 WO0119778
 WO0119780
 WO0242301
 WO02070462
 WO02070510
 WO03095451
 WO2008052934
 WO2011147809
 WO2012004258
 WO2012028647
 WO2012059549
 WO2012112363
 WO2015017305
 WO2015091420
 WO2017097792
 WO2017097671
 WO2018015196
 WO2018228907
 WO2018228909
    - GYIRES et al., "a Adrenoceptor subtypes-mediated physiological, pharmacological actions", Neurochemistry International, (20090000), vol. 55, doi:10.1016/j.neuint.2009.05.014, pages 447 - 453, XP026562407

DOI:   http://dx.doi.org/10.1016/j.neuint.2009.05.014
    - TANLIMBIRD, "The a Adrenergic Receptors", Adrenergic Receptors in the 21st Century/Receptors, (20050000), pages 241 - 265
    - JORDAN ASWHITE DPLO YL et al., "Airway dilator muscle activity and lung volume during stable breathing in obstructive sleep apnea", Sleep, (20090000), vol. 32, no. 3, pages 361 - 8
    - HOMER R.L., "Neuromodulation of hypoglossal motoneurons during sleep", Respir Physiol Neurobiol, (20080000), vol. 164, no. 1-2, doi:10.1016/j.resp.2008.06.012, pages 179 - 196, XP025561340

DOI:   http://dx.doi.org/10.1016/j.resp.2008.06.012
    - VRINTS et al., Acta Clin Belg, (20130000), vol. 68, pages 169 - 78
    - HEIN L et al., "Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission", Nature, (19990000), vol. 402, no. 6758, pages 181 - 184
    - HOLLANDT et al., HNO, (20000000), vol. 48, pages 628 - 634
    - ECKERT D.J. et al., "Central sleep apnea: Pathophysiology and treatment", Chest, (20070000), vol. 131, no. 2, pages 595 - 607
    - ARENS C., "Position paper of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery and the German Society of Phoniatrics and Pediatric Audiology - current state of clinical and endoscopic diagnostics, evaluation, and therapy of swallowing disorders in children and adults", Laryngorhinootologie, (20150300), vol. 1, pages 306 - 54
    - KARKOS PD, "Current evaluation of the dysphagic patient", Hippokratia, (20090700), vol. 13, no. 3, pages 141 - 6
    - YAMANISHI T., "Alpha2-adrenoceptors coordinate swallowing and respiration", J Dent Res, (20100000), vol. 89, no. 3, pages 258 - 2639
    - KANAGY, Clinical Science, (20050000), vol. 109, pages 431 - 437
    - GYIRES et al., "a -Adrenoceptor subtypes-mediated physiological, pharmacological actions", Neurochemistry International, (20090000), vol. 55, doi:10.1016/j.neuint.2009.05.014, pages 447 - 453, XP026562407

DOI:   http://dx.doi.org/10.1016/j.neuint.2009.05.014
    - CHOTANI et al., "Silent a adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries", Am J Physiol, (20000000), vol. 278, pages H1075 - H1083
    - CHOTANI et al., "Distinct cAMP signaling pathways differentially regulate a adrenenoxceptor expression: role in serum induction in human arteriolar smooth muscle cells", Am J Physiol Heart Circ Physiol, (20050000), vol. 288, pages H69 - H76
    - KEENANPORTER, "a Adrenergic receptors in platelets from patients with Raynaud's syndrome", Surgery, (19830000), vol. V94, no. 2
    - "Isotopic Compositions of the Elements 1997", Pure Appl. Chem., (19980000), vol. 70, no. 1, pages 217 - 235
    - H. J. LEIS et al., Curr. Org. Chem., (19980000), vol. 2, page 131
    - ESAKI et al., Tetrahedron, (20060000), vol. 62, page 10954
    - ESAKI et al., Chem. Eur. J., (20070000), vol. 13, page 4052
    - J. R. MORANDI et al., J. Org. Chem., (19690000), vol. 34, no. 6, page 1889
    - N. H. KHAN, J. Am. Chem. Soc., (19520000), vol. 74, no. 12, page 3018
    - S. CHANDRASEKHAR et al., Tetrahedron, (20110000), vol. 52, no. 3865
    - HANZLIK et al., J. Org. Chem., (19900000), vol. 55, pages 3992 - 3997
    - R. P. HANZLIK et al., Biochem. Biophys. Res. Commun., (19890000), vol. 160, page 844
    - P. J. REIDER et al., J Org. Chem., (19870000), vol. 52, pages 3326 - 3334
    - M. JARMAN et al., Carcinogenesis, (19930000), vol. 16, no. 4, pages 683 - 688
    - J. ATZRODT et al., Angew. Chem., Int. Ed., (20070000), vol. 46, page 7744
    - K. MATOISHI et al., J. Chem. Soc, Chem. Commun., (20000000), pages 1519 - 1520
    - A. STREITWIESER et al., J. Am. Chem. Soc., (19630000), vol. 85, page 2759
    - C. L. PERRIN et al., J. Am. Chem. Soc., (20070000), vol. 129, page 4490
    - C. L. PERRIN et al., J. Am. Chem. Soc., (20030000), vol. 125, page 15008
    - C. L. PERRIN, Advances in Physical Organic Chemistry, vol. 44, page 144
    - C. L. PERRIN et al., J. Am. Chem. Soc., (20050000), vol. 127, page 9641
    - B. TESTA et al., Int. J. Pharm., (19840000), vol. 19, no. 3, page 271
    - D. J. KUSHNER et al., Can. J. Physiol. Pharmacol., (19990000), vol. 77, page 79
    - A. E. MUTLIB et al., Toxicol. Appl. Pharmacol., (20000000), vol. 169, page 102
    - A. M. SHARMA et al., Chem. Res. Toxicol., (20130000), vol. 26, page 410
    - UETRECHT et al., Chemical Research in Toxicology, (20080000), vol. 21, no. 9, page 1862
    - A. J. MORALES et al., The 15th North American Meeting of the International Society of Xenobiotics, (20081012), vol. 285
    - C. J. WENTHUR et al., J. Med. Chem., (20130000), vol. 56, page 5208
    - F. SCHNEIDER et al., Arzneim. Forsch. Drug. Res., (20060000), vol. 56, page 295
    - F. MALTAIS et al., J. Med. Chem., (20090000), vol. 52, page 7993
    - Citation of NMR Peaklist Data within Patent Applications, (20140801), URL: http://www.researchdisclosure.com/searching-disclosures
    - CAS, no. 1799475-27-6
    - CHENG YPRUSOFF WH, "Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction", Biochem Pharmacol, vol. 22, no. 23, doi:10.1016/0006-2952(73)90196-2, pages 3099 - 108, XP000942582

DOI:   http://dx.doi.org/10.1016/0006-2952(73)90196-2
    - WUNDER F.KALTHOF B.MULLER T.HUESER J., "Functional Cell-Based Assays in Microliter Volumes for Ultra-High Throughput Screening", Combinatorial Chemistry & High Throughput Screening, (20080000), vol. 11, no. 7, pages 495 - 504
    - WIRTH et al., Sleep, (20130000), vol. 36, pages 699 - 708
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.